SCHEMBL28795452

SCHEMBL28795452

CC(C)C[C@H](N)C(=O)N1CCN(CCCCC(=O)O)CC1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 12/20 0.54
HRH1 P35367 12/20 0.54
OPRK1 P41145 3/20 0.42
CYP1A2 P05177 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PAOX Q6QHF9 1/20 0.39
SLC7A5 Q01650 1/20 0.39
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
DPP7 Q9UHL4 1/20 0.37
HTR1A P08908 1/20 0.37
HTR7 P34969 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27945276 0.85 HRH2 (0.51) HRH2HRH1OPRK1CYP1A2MAPK1
SCHEMBL27839020 0.83 HRH2 (0.51) HRH2HRH1OPRK1CYP1A2MAPK1
SCHEMBL27856827 0.82 HRH2 (0.47) HRH2HRH1OPRK1CYP1A2MAPK1
SCHEMBL27926403 0.80 HRH2 (0.48) HRH2HRH1OPRK1CYP1A2MAPK1
SCHEMBL17152649 0.77 PIK3CD (0.58) HRH2HRH1SLC7A5DPP4DPP8
SCHEMBL20413344 0.77 HRH2 (0.47) HRH2HRH1SLC7A5DPP4DPP8
SCHEMBL20413342 0.77 DPP4 (0.45) HRH2HRH1CYP1A2SLC7A5DPP4
SCHEMBL13995145 0.77 DPP4 (0.45) HRH2HRH1CYP1A2SLC7A5DPP4
SCHEMBL27945272 0.76 OPRK1 (0.59) HRH2HRH1OPRK1
Hydrochloric Acid SCHEMBL10861194 0.76 HRH2 (0.46) HRH2HRH1SLC7A5DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102369197-B 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as ADP receptor antagonists ACTELION PHARMACEUTICALS LTD 2013-11-06 CN disclosed
CN-102369197-A 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as adp receptor antagonists ACTELION PHARMACEUTICALS LTD 2012-03-07 CN disclosed